Literature DB >> 1312127

Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.

H Ghiasi1, R Kaiwar, A B Nesburn, S L Wechsler.   

Abstract

We have shown previously that herpes simplex virus type 1 (HSV-1) glycoprotein H (gH) expressed by a baculovirus recombinant is transported to the cell surface in the absence of other HSV-1 gene products, and that the expressed gH has an apparent Mr similar to that of authentic HSV-1 gH. We report here that antibodies raised in mice to this baculovirus-expressed gH neutralize the infectivity of HSV-1 in vitro; this neutralizing activity was not complement-dependent. Mice vaccinated with gH also developed delayed type hypersensitivity (DTH) to HSV-1. This is the first report of expressed HSV-1 gH inducing neutralizing antibody or DTH responses in vaccinated animals. In contrast to the gH expressed in mammalian systems, the ability of this baculovirus-expressed gH to induce a neutralizing antibody response may be due to the inability of the mammalian expression system to transport gH to the cell surface. Despite inducing anti-HSV-1 neutralizing antibody and DTH responses, vaccination of mice with gH did not protect the mice against lethal intraperitoneal challenge with HSV-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312127     DOI: 10.1099/0022-1317-73-3-719

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H.

Authors:  B G Klupp; W Fuchs; E Weiland; T C Mettenleiter
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Glycoprotein H of herpes simplex virus type 1 requires glycoprotein L for transport to the surfaces of insect cells.

Authors:  D F Westra; K L Glazenburg; M C Harmsen; A Tiran; A Jan Scheffer; G W Welling; T Hauw The; S Welling-Wester
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

Authors:  C Naftzger; Y Takechi; H Kohda; I Hara; S Vijayasaradhi; A N Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Mutations within the pathogenic region of herpes simplex virus 1 gK signal sequences alter cell surface expression and neurovirulence.

Authors:  Harry H Matundan; Kevin R Mott; Aslam Abbasi Akhtar; Joshua J Breunig; Homayon Ghiasi
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

5.  Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL.

Authors:  B G Klupp; J Baumeister; A Karger; N Visser; T C Mettenleiter
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.

Authors:  H Ghiasi; R Kaiwar; S Slanina; A B Nesburn; S L Wechsler
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus.

Authors:  E M McGowan; M B Hayden; S J Edwards; D Pye; D N Love; J M Whalley
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus.

Authors:  D N Love; C W Bell; D Pye; S Edwards; M Hayden; G L Lawrence; D Boyle; T Pye; J M Whalley
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K.

Authors:  H Ghiasi; S Slanina; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.

Authors:  H Ghiasi; R Kaiwar; A B Nesburn; S Slanina; S L Wechsler
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.